Welcome to the Miller Lab at the Medical College of Wisconsin Cancer Center. Our lab is focused on understanding the causes of drug resistance in breast cancer and the discovery of new treatment strategies.
Combined Radiation and Endocrine Therapies Elicit Benefit in ER+ Breast Cancer.
Anneka L Johnson, Steven Tau, Austin M Sloop, Tianyuan Dai, Alyssa M Roberts, Patricia Muskus, Alexa Warren, Sierra A Kleist, Riley A Hampsch, Julie M Jorns, Rongxiao Zhang, Lesley A Jarvis, Todd W Miller.
Cancers (Basel). 2025 Jun 9;17(12):1921. doi: 10.3390/cancers17121921.
Reply to: "Comments on the paper 'Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer' by Y. Chen et al.".
Youdinghuan Chen, Lucas A Salas, Jonathan D Marotti, Nicole P Jenkins, Chao Cheng, Todd W Miller, Arminja N Kettenbach, Brock C Christensen.
Int J Cancer. 2025 Aug 1;157(3):590-591. doi: 10.1002/ijc.35434. Epub 2025 Apr 18.
Quantitative proteomics analysis of triple-negative breast cancers.
Natasha C Mariano, Jonathan D Marotti, Youdinghuan Chen, Barbara Karakyriakou, Roberto Salgado, Brock C Christensen, Todd W Miller, Arminja N Kettenbach.
NPJ Precis Oncol. 2025 Apr 24;9(1):117. doi: 10.1038/s41698-025-00907-8.